| CXCR1 expression to improve anti-cancer efficacy of intravenously injected CAR-NK cells in mice with peritoneal xenografts YY Ng, JCK Tay, S Wang Molecular Therapy-Oncolytics 16, 75-85, 2020 | 106 | 2020 |
| Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis WX Ang, Z Li, Z Chi, SH Du, C Chen, JCK Tay, HC Toh, JE Connolly, ... Oncotarget 8 (8), 13545, 2017 | 102 | 2017 |
| Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells H Zhu, CH Lau, SL Goh, Q Liang, C Chen, S Du, RZ Phang, FC Tay, ... Nucleic acids research 41 (19), e180-e180, 2013 | 65 | 2013 |
| Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor–modified effector cells L Xiao, C Chen, Z Li, S Zhu, JCK Tay, X Zhang, S Zha, J Zeng, WK Tan, ... Cytotherapy 20 (3), 420-435, 2018 | 53 | 2018 |
| T cells expressing NKG2D CAR with a DAP12 signaling domain stimulate lower cytokine production while effective in tumor eradication YY Ng, JCK Tay, Z Li, J Wang, J Zhu, S Wang Molecular Therapy 29 (1), 75-85, 2021 | 44 | 2021 |
| Electroporation of NKG2D RNA CAR improves Vγ9Vδ2 T cell responses against human solid tumor xenografts WX Ang, YY Ng, L Xiao, C Chen, Z Li, Z Chi, JCK Tay, WK Tan, J Zeng, ... Molecular Therapy-Oncolytics 17, 421-430, 2020 | 34 | 2020 |
| Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent … RZ Phang, FC Tay, SL Goh, CH Lau, H Zhu, WK Tan, Q Liang, C Chen, ... Stem cells translational medicine 2 (12), 935-945, 2013 | 34 | 2013 |
| Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system CH Lau, H Zhu, JCK Tay, Z Li, FC Tay, C Chen, WK Tan, S Du, VK Sia, ... Molecular Therapy-Methods & Clinical Development 1, 2014 | 19 | 2014 |
| Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells JCK Tay, J Wang, Z Du, YY Ng, Z Li, Y Ren, C Zhang, J Zhu, XH Xu, ... Molecular Therapy-Methods & Clinical Development 21, 107-120, 2021 | 18 | 2021 |
| Expansion of gamma delta T Cells-A short review on bisphosphonate and K562-Based methods WK Tan, JCK Tay, J Zeng, M Zheng, S Wang Journal of Immunological Sciences 2 (2), 2018 | 16 | 2018 |
| Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion SH Du, JCK Tay, C Chen, FC Tay, WK Tan, ZD Li, S Wang Journal of bioscience and bioengineering 120 (2), 210-217, 2015 | 14 | 2015 |
| Generation of mesenchymal stromal cells with low immunogenicity from human PBMC-derived β2 microglobulin knockout induced pluripotent stem cells S Zha, JCK Tay, S Zhu, Z Li, Z Du, S Wang Cell Transplantation 29, 0963689720965529, 2020 | 13 | 2020 |
| Experimental treatment of colorectal cancer in mice with human T cells electroporated with NKG2D RNA CAR Z Li, Z Chi, WX Ang, C Chen, JCK Tay, YY Ng, X Xu, J Wang, J Zhu, ... Immunotherapy 12 (10), 733-748, 2020 | 11 | 2020 |
| Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers JCK Tay, S Zha, S Wang Immunotherapy 9 (16), 1339-1349, 2017 | 11 | 2017 |
| Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis G Jiang, YY Ng, JCK Tay, Z Du, L Xiao, S Wang, J Zhu Cancer Immunology, Immunotherapy 72 (1), 223-234, 2023 | 10 | 2023 |
| Beta-2 microglobulin knockout K562 cell-based artificial antigen presenting cells for ex vivo expansion of T lymphocytes S Zha, Z Li, C Chen, Z Du, JCK Tay, S Wang Immunotherapy 11 (11), 967-982, 2019 | 7 | 2019 |
| Electroporation of NKG2D RNA CAR Improves Vg9Vd2 T Cell Responses against Human Solid Tumor Xenografts WX Ang, YY Ng, L Xiao, C Chen, Z Li, Z Chi, JCK Tay, WK Tan, J Zeng, ... cancer 8, 10, 0 | | |
